PCI Pharma extends global clinical supply-chain services in Europe
By Akshay Kedari  Date: 2020-07-30

PCI Pharma extends global clinical supply-chain services in Europe

U.S. based biopharmaceutical and pharma outsourcing services company, PCI Pharma services has reportedly announced that it reached a noteworthy milestone through the development of COE (Clinical Center of Excellence) in Berlin.

According to credible sources, the new COE facility is PCI Pharma’s efforts to extend its clinical supply-chain network in Europe, which would complement the existing services it provides in Ireland and UK.

The Berlin-based COE will cover a space of 17,000 square feet which will primarily focus on packaging, storing and distribution of pharmaceutical and biopharmaceutical therapies in Europe, sources claimed.

The facility is reportedly ideal to provide services to clinical trials eco-system in the region. It presently has around 38,100 active trial centers across Europe, of which France ranks first with 7,370 active trials followed by Germany, with around 4,418 trial centers.

VP and GM of Global Clinical Operations & Supply at PCI Pharma Services, Brian Keesee reportedly said that this expansion will enable the company to cater to the needs of European as well as global clients through the COE facility in Berlin. He further claimed that Berlin is an exceptional logistics center and will ensure minimum disruptions in the supply-chain amid Brexit.

Salim Haffar, CEO at PCI Pharma Services, also stated that the company’s strategy has always focused on increasing the capacity as well as the capabilities of its network of clinical trial services. He added that the recent acquisition of Bellwyck Pharma Services will enable PCI Pharma to improve its capabilities through the Berlin facility, in a bid to support the flourishing clinical trial sector in Europe.

Salim also confirmed that the recent investment will facilitate the company to offer clinical trial solutions of their advanced medicines to clients across the globe.

For those uninitiated, PCI Pharma is a major contributor to global healthcare industry since it offers drug development solutions that help in enhancing numerous medical products.

Source credits: https://www.businesswire.com/news/home/20200728005211/en/PCI-Pharma-Services-Announces-Global-Expansion-Clinical

About Author

Akshay Kedari    

Akshay Kedari

A qualified computer engineering graduate, Akshay Kedari takes pride in having his way with words. Following his passion for content creation, he writes insightful pieces on aeresearch.net and a few other portals. Also endorsed with a short-term experience in web deve...

Read More

More News By Akshay Kedari

FMCG firms resort to marginal hike to cope with raw material inflation
FMCG firms resort to marginal hike to cope with raw material inflation
By Akshay Kedari

The recent inflation in raw materials has reportedly prompted players in the FMCG sector to take price hike measures for their products, in a bid to maintain the revenues. According to reliable sources, some FMCG companies, including Marico, have al...

boAt raises USD 100 million in funding from Warburg Pincus
boAt raises USD 100 million in funding from Warburg Pincus
By Akshay Kedari

Indian consumer electronics brand, boAt, has reportedly secured funding of USD 100 million from Warburg Pincus, a New-York-based private equity firm, at a USD 300 million valuation. The company will utilize these funds to expand its product portfoli...

Elevar Therapeutics and Inceptua partner to commercialize Apealea®
Elevar Therapeutics and Inceptua partner to commercialize Apealea®
By Akshay Kedari

According to reliable sources, U.S.-based fully integrated biopharmaceutical company, Elevar Therapeutics Inc., has signed an exclusive agreement with Inceptua Group for the commercialization and distribution of its non-cremophor based paclitaxel tre...

NASA completes construction of ‘LC-48’ at Kennedy Space Center
NASA completes construction of ‘LC-48’ at Kennedy Space Center
By Akshay Kedari

The National Aeronautics and Space Administration (NASA) has reportedly announced the completion of the construction of its new launchpad at the Kennedy Space Center based in Florida. Notably, the new Launch Complex 48 or LC-48 is a pad that will be ...

How are energy storage applications driving conductive polymers demand?
How are energy storage applications driving conductive polymers demand?
By Akshay Kedari

With viable environmental stability and mechanical upsides, conductive polymers market players are gearing to infuse funds in the sector. Considered as the 4th generation of polymeric materials, one of the major selling points of conductive polymers ...